Ken Maes
8PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 18, 2023
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.Rong Fan, Hatice Satilmis, Niels Vandewalle
|Jan 17, 2023
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.Rong Fan, Hatice Satilmis, Niels Vandewalle
|Oct 14, 2022
Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study.Robbe Heestermans, Wouter De Brouwer, Ken Maes
|May 03, 2021
G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor-mediated cell death.Eva De Smedt, Julie Devin, Catharina Muylaert
|Nov 20, 2019
Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.Anke Maes, Ken Maes, Philip Vlummens
|Nov 08, 2019
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma.Siyang Yan, Niels Vandewalle, Nathan De Beule
Pageof 2
Frequent Collaborators
5 joint publications
Elke De Bruyne
4 joint publications
Eline Menu
3 joint publications
Kim De Veirman
2 joint publications
Jerome Moreaux
1 joint publications
Lien De Beck
1 joint publications
Siyang Yan
1 joint publications
Guillaume Cartron
1 joint publications
Robbe Heestermans
1 joint publications
Freya Vaeyens
1 joint publications
Ivan Van Riet
